Shopping Cart
- Remove All
- Your shopping cart is currently empty
GYKI 52466 dihydrochloride (GYKI 52466 2HCl) is a highly potent, orally active and selective AMPA/Kainate receptor antagonist with good blood-brain permeability and anticonvulsant activity that can be used to study neurological diseases such as Parkinson's and epilepsy.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | $113 | In Stock |
Description | GYKI 52466 dihydrochloride (GYKI 52466 2HCl) is a highly potent, orally active and selective AMPA/Kainate receptor antagonist with good blood-brain permeability and anticonvulsant activity that can be used to study neurological diseases such as Parkinson's and epilepsy. |
Targets&IC50 | AMPA receptor:11 μM , Kainate receptor:7.5 μM |
In vitro | In cultured rat hippocampal neurons, GYKI 52466 dihydrochloride (0.3-100 μM) was able to inhibit inward currents activated by AMPA and Kainate receptors. [1] |
In vivo | GYKI 52466 dihydrochloride (1.76-13.2 mg/kg; single administration), given by intraperitoneal injection to DBA/2 mice, was able to provide effective anticonvulsant protection against sound-induced seizures. [2] |
Alias | GYKI-52466 dihydrochloride, GYKI52466 dihydrochloride, GYKI 52466 2HCl |
Molecular Weight | 366.24 |
Formula | C17H17Cl2N3O2 |
Cas No. | 2319722-40-0 |
Storage | keep away from direct sunlight,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||
Solubility Information | DMSO: 1 mg/mL(2.73 mM), Sonication is recommended. | ||||||||||
Solution Preparation Table | |||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.